Both in Biotechnology
ImmunityBio vs Bio-Techne
Over the past year IBRX returned +245.4% and TECH returned +16.1%; their daily moves had a correlation of -0.00.
IBRX +245.4% TECH +16.1%Growth of $1, one year, split-adjusted
| Metric | IBRX | TECH |
|---|---|---|
| Price | $8.29 | $72.66 |
| Market cap | $8.79B | $11.41B |
| Today | −5.15% | −0.07% |
| 1 month | −10.7% | +0.4% |
| 6 months | +16.6% | +32.1% |
| Year to date | +318.7% | +23.6% |
| 1 year | +242.6% | +17.2% |
| Revenue growth (YoY) | +93.9% | +1.3% |
| Gross margin | 99.4% | 65.8% |
| Net margin | −449.6% | 17.0% |
| P/E (TTM) | — | 62.7× |
| Price / sales | 53.0× | 9.4× |
| Net cash | -$57.7M | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 68.0% | 2.5% |
| Short % of float | 31.1% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).